The future is already here for the medical devices industry as AI- and machine learning-enabled devices and technologies are bringing a slew of benefits, including proactive patient monitoring, faster and safer diagnosis, improved regulatory control, and ultimately, better patient outcomes. Artificial intelligence (AI) is increasingly being integrated into novel medtech products like wearables, point-of-care devices, and software-as-a-medical devices (SaMD) to augment decision-making throughout the healthcare spectrum.
Leading-edge technologies like additive manufacturing also play a prominent role in developing current and new medical device prototypes that are revolutionising the sector, such as medical devices that incorporate bioabsorbable materials as critical components or full-scale regenerative medicine that facilitates the regeneration, repairing, or replacement of tissue or organ.
CROs have become the centrepiece of such advancements by offering end-to-end development services, including medical device testing, regulatory, reimbursement and quality consulting, and clinical research services. As a result, the medical device CRO market is projected to reach $15.7 billion by 2030 at a CAGR of 6.4 percent.
To put the spotlight on such key developments in the domain, MedTech Outlook highlights the vital technological advancements in the medical devices space and how CROs leverage them to augment the development lifecycles of medical device manufacturers. The edition features thought leadership articles from Philippe Heim, Global Business Head – Digitalisation at Belimed, Niklas Best, Director, Head of Digital Products, EMEA, at Fresenius Medical Care, Bruno Campos, Head of Information Systems at Hospital da Luz, and Toufic Kachaamy, Medical Director at Cancer Treatment Centers of America, who throw light on the recent innovations in the medical devices sector and how those advancements are aiding medical device manufacturers to reduce the risk of device recalls and expedite time to market.
In this edition of MedTech Outlook magazine, we also bring you the story of some of the top medical device CROs in Europe that deliver the best outcomes for their clients, including Clinmark, a full-service CRO specialising in clinical research, and 1MED, a regulatory and quality consulting company, and full-service medical devices CRO specialised both on technological and substance-based medical devices, including combination products (drug-device).
Through the following pages, we aim to shine a light on the innovative trends and latest developments in
